| __timestamp | Amphastar Pharmaceuticals, Inc. | Galapagos NV |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 111110000 |
| Thursday, January 1, 2015 | 37065000 | 129714000 |
| Friday, January 1, 2016 | 41199000 | 139574000 |
| Sunday, January 1, 2017 | 43415000 | 218502000 |
| Monday, January 1, 2018 | 57564000 | 322876000 |
| Tuesday, January 1, 2019 | 68853000 | 427320000 |
| Wednesday, January 1, 2020 | 67229000 | 523667000 |
| Friday, January 1, 2021 | 60932000 | 491707000 |
| Saturday, January 1, 2022 | 74771000 | 515083000 |
| Sunday, January 1, 2023 | 73741000 | 241294000 |
Unleashing the power of data
In the ever-evolving world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Amphastar Pharmaceuticals, Inc. and Galapagos NV have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Galapagos NV consistently outpaced Amphastar, with R&D expenses peaking at over 500% higher than Amphastar's in 2020. However, Amphastar showed a steady growth trajectory, increasing its R&D budget by approximately 160% over the same period.
While Galapagos NV's R&D spending saw fluctuations, peaking in 2020 and then declining by 54% by 2023, Amphastar maintained a more consistent upward trend. This divergence highlights differing approaches to innovation and market adaptation. As the pharmaceutical landscape continues to shift, these companies' R&D strategies will play a crucial role in their future success.
Analyzing R&D Budgets: Regeneron Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Galapagos NV
R&D Spending Showdown: Pharming Group N.V. vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Research and Development Expenses Breakdown: Verona Pharma plc vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Amphastar Pharmaceuticals, Inc.
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending
R&D Spending Showdown: Soleno Therapeutics, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Agios Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc. or Amphastar Pharmaceuticals, Inc.: Who Invests More in Innovation?